Rincon lithium project: US$2.5bn cost, 60,000tpa capacity, DLE technology and 2028 production timeline
Read More Pharma Industry News Prana Biotechnology secures FDA orphan drug status for PBT434 to treat multiple system atrophy In a significant milestone, Prana Biotechnology, an Australian biotech company, has obtained Orphan Drug designation from the FDA… bypharmanewsdailyJanuary 31, 2019